Edit |   |
---|---|
Antigenic Specificity | B7-H1 (Simridarlimab biosimilar) |
Clone | monoclonal |
Host Species | Recombinant |
Reactive Species | human |
Isotype | n/a |
Format | Protein A purified |
Size | 100 µg, 1 mg, |
Concentration | 1 mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | This product is for research use only (RUO) by laboratories. It is not suitable for use in humans or as a medicine. Simridarlimab is a Chimeric Humanized monoclonal antibody targeting B7-H1, expressed in Mammalian cells. |
Immunogen | n/a |
Other Names | Simridarlimab, Bispecific, B7-H1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, PDCD1L1, B7 homolog 1, PDCD1LG1, PDL1, hPD-L1, Programmed death ligand 1, B7H1, PD-L1, CD274, Leukocyte surface antigen CD47, CD47, Antigenic surface determinant protein OA3, IAP, Integrin-associated protein, Protein MER6, MER6 |
Gene, Accession # | UniProt: Q9NZQ7, Q08722 |
Catalog # | abx832074 |
Price | please inquire |
Order / More Info | B7-H1 (Simridarlimab biosimilar) Antibody from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950